Octarine Bio in a series A deal with DSM Venturing, Óskare Capital, The Footprint Fund, EIFO, Unconventional Ventures
14 July 2025
14 July 2025
Total investments received (USD): 9.6M
Round value (USD): N/A
Company: Octarine Bio
Related deals
Bluecell Bio to raise capital funding with Kost Capital in Denmark
Investments
08 August 2025
Graspian in an equity deal backed by Foss in Denmark
Investments
02 August 2025
O2matic in an equity financing deal with Euromed, EIFO et al
Investments
18 June 2025
Kripthonite Therapeutics in a seed transaction with Marigold Investment Management.
Investments
11 June 2025
Minerva Imaging in Denmark was acquired by Nordic Capital from Sweden
Secondary
01 June 2025
Belgium
Austria
Germany
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal
Spain
United Kingdom